Cytogenix (fka CYGX)

[holycow]

mea culpa. Disclaimer: this post before my coffee with a headache. After the night, I have reconsidered my last post. While it was always more of a wish than a prediction, I do not now believe that "reality" makes it possible. Front and center right now from the last update is Sarbanes Oxley and arbitration. It's "what's for dinner" and investors don't much like the taste of this dish. The company has been through worse. It sounds like the SEC decision to have this matter dealt with as part of the arbitration was a victory. The board's action to launch an investigation, the SEC's request for information, perhaps pro forma, are indications that the matter is not yet over. Ongoing developments in this area is likely the reason the update was held up. Until these matters are squarely behind us, I do not expect major developments. I hate to admit it, but so far, skooby's analysis of the implications of the officers leaving has been more accurate than my own.